Citations

Citations to this article as recorded by  

• Deep Learning Model Using Stool Pictures for Predicting Endoscopic Mucosal Inflammation in Patients With Ulcerative Colitis
  Jung Won Lee, Dongwon Woo, Kyeong Ok Kim, Eun Soo Kim, Sung Kook Kim, Hyun Seok Lee, Ben Kang, Yoo Jin Lee, Jeongseok Kim, Byung Ik Jang, Eun Young Kim, Hyeong Ho Jo, Yun Jin Chung, Hanjun Ryu, Soo-Kyung Park, Dong-Il Park, Hosang Yu, Sungmoon Jeong
  American Journal of Gastroenterology.2025; 120(1): 213.     CrossRef
• Could histologic healing be a new treatment target in patients with ulcerative colitis?
  Soyoung Kim, Sang Hyoung Park
  The Korean Journal of Internal Medicine.2024; 39(1): 2.     CrossRef
• From Data to Insights: How Is AI Revolutionizing Small-Bowel Endoscopy?
  Joana Mota, Maria João Almeida, Francisco Mendes, Miguel Martins, Tiago Ribeiro, João Afonso, Pedro Cardoso, Helder Cardoso, Patrícia Andrade, João Ferreira, Miguel Mascarenhas, Guilherme Macedo
  Diagnostics.2024; 14(3): 291.     CrossRef
• The Role of Artificial Intelligence in the Diagnosis and Treatment of Ulcerative Colitis
  Petar Uchikov, Usman Khalid, Nikola Vankov, Maria Kraeva, Krasimir Kraev, Bozhidar Hristov, Milena Sandeva, Snezhanka Dragusheva, Dzhevdet Chakarov, Petko Petrov, Bistra Dobreva-Yatseva, Ivan Novakov
  Diagnostics.2024; 14(10): 1004.     CrossRef
• Deep learning and minimally invasive inflammatory activity assessment: a proof-of-concept study for development and score correlation of a panendoscopy convolutional network
  Pedro Cardoso, Miguel Mascarenhas, João Afonso, Tiago Ribeiro, Francisco Mendes, Miguel Martins, Patrícia Andrade, Hélder Cardoso, Miguel Mascarenhas Saraiva, João P.S. Ferreira, Guilherme Macedo
  Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
• Knowledge, attitudes, and practices of endoscopy among gastroenterologists in diagnosis and management of inflammatory bowel disease in China: a multicenter cross-sectional study
  Yinghao Sun, Gechong Ruan, Xiaoyin Bai, Wei Han, Minglan Yang, Lixin Jin, Yanni Huang, Xiaoxia Hou, Ke Shu, Yingying Liu, Yafeng Lu, Yan Zhao, Jie Zhong, Hong Yang
  BMC Gastroenterology.2024;[Epub]     CrossRef
• Endoscopic findings of immune checkpoint inhibitor-related gastrointestinal adverse events
  Min Kyu Kim, Sung Wook Hwang
  Clinical Endoscopy.2024; 57(6): 725.     CrossRef
• The pathobiology of follicular lymphoma
  Joaquim Carreras
  Journal of Clinical and Experimental Hematopathology.2023; 63(3): 152.     CrossRef
• Artificial Intelligence in Digestive Endoscopy—Where Are We and Where Are We Going?
  Radu-Alexandru Vulpoi, Mihaela Luca, Adrian Ciobanu, Andrei Olteanu, Oana-Bogdana Barboi, Vasile Liviu Drug
  Diagnostics.2022; 12(4): 927.     CrossRef
• Artificial intelligence within the small bowel: are we lagging behind?
  Stefania Chetcuti Zammit, Reena Sidhu
  Current Opinion in Gastroenterology.2022; 38(3): 307.     CrossRef

Citations

Citations to this article as recorded by  

• Clinical effectiveness and safety of ustekinumab in youth with refractory inflammatory bowel disease: A retrospective cohort study
  Abdulhamid Alhadab, Amal Almarhoon, Amena AlAlwan, AbdelHai Hammo
  Saudi Journal of Gastroenterology.2025; 31(2): 59.     CrossRef
• Oral manifestations of Crohn disease managed with ustekinumab
  Patrick Ruck, Elizabeth S. Gosnell, James R. Rick
  The Journal of the American Dental Association.2025; 156(2): 160.     CrossRef
• STEP-CD study: ustekinumab use in paediatric Crohn’s disease—a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN
  Gemma Pujol-Muncunill, Víctor Manuel Navas-López, Oren Ledder, Shlomi Cohen, Marina Lekar, Dan Turner, Kaija-Leena Kolho, Arie Levine, Nicholas M. Croft, Jiri Bronsky, Dror S. Shouval, Amit Assa, Rachel Harris, Fevronia Kiparissi, Marina Aloi, Nadeem Ahma
  European Journal of Pediatrics.2024; 183(8): 3253.     CrossRef
• Medical management of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group
  Way Seah Lee, Katsuhiro Arai, George Alex, Suporn Treepongkaruna, Kyung Mo Kim, Chee Liang Choong, Karen S. C. Mercado, Andy Darma, Anshu Srivastava, Marion M. Aw
  Journal of Gastroenterology and Hepatology.2023; 38(4): 523.     CrossRef
• Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
  Kyunghwan Oh, Hee Seung Hong, Nam Seok Ham, Jungbok Lee, Sang Hyoung Park, Suk-Kyun Yang, Hyuk Yoon, You Sun Kim, Chang Hwan Choi, Byong Duk Ye
  Intestinal Research.2023; 21(1): 137.     CrossRef
• Effectiveness and Safety of Ustekinumab for Pediatric Inflammatory Bowel Disease: A Systematic Review
  Shengbo Fang, Sixi Zhang, Chunyan Zhang, Libo Wang
  Pediatric Drugs.2023; 25(5): 499.     CrossRef
• Real-World Evidence of the Effectiveness and Safety of Ustekinumab for the Treatment of Crohn’s Disease: Systematic Review and Meta-Analysis of Observational Studies
  Cristina Rubín de Célix, María Chaparro, Javier P. Gisbert
  Journal of Clinical Medicine.2022; 11(14): 4202.     CrossRef
• Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugs
  Soo-Young Na, You Sun Kim
  The Korean Journal of Internal Medicine.2022; 37(5): 906.     CrossRef
• Augmented ustekinumab dosing is needed to achieve clinical response in patients with anti-TNF refractory pediatric Crohn’s disease: a retrospective chart review
  Phinga Do, John Andersen, Ashish Patel, Gaith Semrin, Luis Sifuentes-Dominguez, Phuong Luu, Bhaskar Gurram
  F1000Research.2021; 9: 316.     CrossRef
• Ustekinumab Dose Intensification in Paediatric Crohn's Disease
  Rosa Rodríguez‐Mauriz, Carlos Seguí Solanes, Isabel Masiques Mas, Nuria Rudi Sola
  Journal of Paediatrics and Child Health.2021; 57(7): 1148.     CrossRef

Citations

Citations to this article as recorded by  

• Impact of twice‐daily budesonide foam administration on early clinical response and endoscopic remission in patients with ulcerative colitis: a post hoc analysis
  Kenji Watanabe, Fumihito Hirai, Kiyonori Kobayashi, Ken Takeuchi, Shinsuke Kurosu, Katsutoshi Inagaki, Ken‐ichi Iwayama, Makoto Naganuma
  Journal of Gastroenterology and Hepatology.2024; 39(11): 2367.     CrossRef
• Precision medicine and drug optimization in adult inflammatory bowel disease patients
  Sophie Vieujean, Edouard Louis
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• The Prognostic Value of Residual Nonrectal Inflammation in Ulcerative Colitis
  Eun Ae Kang
  Gut and Liver.2022; 16(3): 487.     CrossRef
• Bowel frequency (night) and urgent defecation are improved by budesonide foam in patients with ulcerative colitis: a retrospective observational study
  Ryosuke Miyazaki, Toshiyuki Sakurai, Mariko Shimada, Yuko Iwashita, Naoki Shibuya, Yoshihiro Akita, Haruna Miyashita, Yuki Maruyama, Masayuki Saruta
  BMC Gastroenterology.2022;[Epub]     CrossRef
• Personalized medicine in inflammatory bowel disease: Perspectives on Asia
  Su Hyun Park, Sang Hyoung Park
  Journal of Gastroenterology and Hepatology.2022; 37(8): 1434.     CrossRef
• Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
  Jihye Park, Jae Hee Cheon
  The Korean Journal of Internal Medicine.2022; 37(5): 895.     CrossRef
• Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
  Giovanni Maconi, Deborah Camatta, Rosanna Cannatelli, Francesca Ferretti, Anna Carvalhas Gabrielli, Sandro Ardizzone
  Therapeutics and Clinical Risk Management.2021; Volume 17: 285.     CrossRef

Citations

Citations to this article as recorded by  

• Mesenchymal stem cell-derived exosomes as a plausible immunomodulatory therapeutic tool for inflammatory diseases
  Muhammad Zubair, Fatma A. Abouelnazar, Muhammad Asad Iqbal, Jingyun Pan, Xuwen Zheng, Tao Chen, Wenming Shen, Jinnan Yin, Yongmin Yan, Pengjun Liu, Fei Mao, Ying Chu
  Frontiers in Cell and Developmental Biology.2025;[Epub]     CrossRef
• Myths and Realities about the Private Sector Stem Cell Industry in Malaysia
  Kean Chang Phang, Mohammad Firdaus Bin Abdul Aziz
  Asian Bioethics Review.2025;[Epub]     CrossRef
• The nasal basal cell population shifts toward a diseased phenotype with impaired barrier formation capacity in allergic rhinitis
  Emma Ruysseveldt, Brecht Steelant, Tine Wils, Jonathan Cremer, Dominique M.A. Bullens, Peter W. Hellings, Katleen Martens
  Journal of Allergy and Clinical Immunology.2024; 154(3): 631.     CrossRef
• Cellular Plasticity in Gut and Liver Regeneration
  Minwook Kim, Yoojeong Park, You Sun Kim, Sungjin Ko
  Gut and Liver.2024; 18(6): 949.     CrossRef
• Revolutionizing medicine: recent developments and future prospects in stem-cell therapy
  Bashdar M. Hussen, Mohammad Taheri, Raya Kh. Yashooa, Gaylany H. Abdullah, Snur R. Abdullah, Ramiar Kamal Kheder, Suhad A. Mustafa
  International Journal of Surgery.2024; 110(12): 8002.     CrossRef
• Nigakinone alleviates DSS‐induced experimental colitis via regulating bile acid profile and FXR/NLRP3 signaling pathways
  Fangle Liu, Yufeng Yao, Qian Wang, Fengxue Zhang, Meiqi Wang, Chenchen Zhu, Chaozhan Lin
  Phytotherapy Research.2023; 37(1): 15.     CrossRef
• TNFα Induces LGR5+ Stem Cell Dysfunction In Patients With Crohn’s Disease
  Chansu Lee, Minae An, Je-Gun Joung, Woong-Yang Park, Dong Kyung Chang, Young-Ho Kim, Sung Noh Hong
  Cellular and Molecular Gastroenterology and Hepatology.2022; 13(3): 789.     CrossRef
• Bovine colostrum derived-exosomes prevent dextran sulfate sodium-induced intestinal colitis via suppression of inflammation and oxidative stress
  Geonhee Han, Haeun Cho, Hyosuk Kim, Yeongji Jang, Hochung Jang, Da Eun Kim, Eun Sun Kim, Eun Hye Kim, Kwang Yeon Hwang, Kwangmeyung Kim, Yoosoo Yang, Sun Hwa Kim
  Biomaterials Science.2022; 10(8): 2076.     CrossRef
• The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer
  Gang Guo, Zhaobang Tan, Yaping Liu, Feiyu Shi, Junjun She
  Stem Cell Research & Therapy.2022;[Epub]     CrossRef
• Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases
  Zhengping Che, Ziyu Ye, Xueying Zhang, Bihua Lin, Weiqing Yang, Yanfang Liang, Jincheng Zeng
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Mechanotransduction through adhesion molecules: Emerging roles in regulating the stem cell niche
  Ryan Lim, Avinanda Banerjee, Ritusree Biswas, Anana Nandakumar Chari, Srikala Raghavan
  Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
• Clinical applications and optimization of patient-derived organoids in intestinal diseases
  Tae Il Kim
  Organoid.2022; 2: e22.     CrossRef
• Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
  Jinsha Liu, Joey Paolo Ting, Shams Al-Azzam, Yun Ding, Sepideh Afshar
  International Journal of Molecular Sciences.2021; 22(6): 2805.     CrossRef
• Comparative perianal fistula closure rates following autologous adipose tissue-derived stem cell transplantation or treatment with anti-tumor necrosis factor agents after seton placement in patients with Crohn’s disease: a retrospective observational stud
  Min Young Park, Yong Sik Yoon, Jong Lyul Lee, Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang, Chang Sik Yu
  Stem Cell Research & Therapy.2021;[Epub]     CrossRef
• Current Trends and Research Topics Regarding Intestinal Organoids: An Overview Based on Bibliometrics
  Meng-Meng Zhang, Ke-Lu Yang, Yan-Cheng Cui, Yu-Shi Zhou, Hao-Ran Zhang, Quan Wang, Ying-Jiang Ye, Shan Wang, Ke-Wei Jiang
  Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
• The Potential of Vitamin D3 to Repaired Mucosal Injury in Dextran Sulfate Sodium Induced Acute Colitis in Mice
  Satrio Wibowo, Krisni Subandiyah, Kusworini Handono, Sri Poeranto
  Open Access Macedonian Journal of Medical Sciences.2021; 9(B): 931.     CrossRef
• Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease: A review
  Ji Young Chang, Jae Hee Cheon
  Precision and Future Medicine.2021; 5(4): 151.     CrossRef
• Mutual regulation between butyrate and hypoxia‐inducible factor‐1α in epithelial cell promotes expression of tight junction proteins
  Jiuheng Yin, Chao Zhou, Kunqiu Yang, Yanbei Ren, Yuan Qiu, Pengyuan Xu, Weidong Xiao, Hua Yang
  Cell Biology International.2020; 44(6): 1405.     CrossRef
• Letter: off‐label use of hyperbaric oxygen therapy in inflammatory bowel disease—Authors’ reply
  Melek Simsek, Nanne K. H. de Boer
  Alimentary Pharmacology & Therapeutics.2020; 52(1): 216.     CrossRef
• The Role of Immune and Epithelial Stem Cells in Inflammatory Bowel Disease Therapy
  Agata Binienda, Sylwia Ziolkowska, Ingvild H. Hauge, Maciej Salaga
  Current Drug Targets.2020; 21(14): 1405.     CrossRef

Citations

Citations to this article as recorded by  

• Systematic scoping review: Use of the faecal immunochemical test residual buffer to enhance colorectal cancer screening
  Timothy McAuliffe, Joseph C. Anderson, Robin J. Larson, Douglas J. Robertson
  Alimentary Pharmacology & Therapeutics.2024; 59(9): 1033.     CrossRef
• Evaluation of a faecal calprotectin method using the OC-SENSOR PLEDIA
  Shane O’Driscoll, Carolyn Piggott, Sally C. Benton
  Clinical Chemistry and Laboratory Medicine (CCLM).2022; 60(6): 901.     CrossRef
• International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases
  Ferdinando D'Amico, David T. Rubin, Paulo Gustavo Kotze, Fernando Magro, Britta Siegmund, Taku Kobayashi, Pablo A. Olivera, Peter Bossuyt, Lieven Pouillon, Edouard Louis, Eugeni Domènech, Subrata Ghosh, Silvio Danese, Laurent Peyrin‐Biroulet
  United European Gastroenterology Journal.2021; 9(4): 451.     CrossRef
• Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis
  Mariusz A. Bromke, Katarzyna Neubauer, Radosław Kempiński, Małgorzata Krzystek-Korpacka
  Journal of Clinical Medicine.2021; 10(10): 2203.     CrossRef
• Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease
  Eriko Yasutomi, Toshihiro Inokuchi, Sakiko Hiraoka, Kensuke Takei, Shoko Igawa, Shumpei Yamamoto, Masayasu Ohmori, Shohei Oka, Yasushi Yamasaki, Hideaki Kinugasa, Masahiro Takahara, Keita Harada, Masaki Furukawa, Kouichi Itoshima, Ken Okada, Fumio Otsuka,
  Scientific Reports.2021;[Epub]     CrossRef
• Optimal Cutoff Level of Fecal Calprotectin for Detecting Small Bowel Inflammation in Crohn's Disease
  Eun Soo Kim
  Gut and Liver.2021; 15(5): 637.     CrossRef
• Fecal calprotectin predicts complete mucosal healing in patients with ulcerative colitis: Systematic review and meta‑analysis
  Zhongsheng Cao, Chenglong Ye, Lunan Li, Xiaoge Geng, Wensheng Pan, Jiyong Jing
  World Academy of Sciences Journal.2021;[Epub]     CrossRef
• Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults
  Małgorzata Krzystek-Korpacka, Radosław Kempiński, Mariusz Bromke, Katarzyna Neubauer
  Diagnostics.2020; 10(6): 367.     CrossRef
• Prostaglandin E-Major Urinary Metabolite Predicts Relapse in Patients With Ulcerative Colitis in Clinical Remission
  Natsuki Ishida, Kiichi Sugiura, Takahiro Miyazu, Satoshi Tamura, Satoshi Suzuki, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
  Clinical and Translational Gastroenterology.2020; 11(12): e00289.     CrossRef
• Prediction of treatment outcome and relapse in inflammatory bowel disease
  Jun Kato, Takeichi Yoshida, Sakiko Hiraoka
  Expert Review of Clinical Immunology.2019; 15(6): 667.     CrossRef

Citations

Citations to this article as recorded by  

• Defining Comprehensive Disease Control for Use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus Recommendations
  Stefan Schreiber, Silvio Danese, Axel Dignass, Eugeni Domènech, Massimo C Fantini, Marc Ferrante, Jonas Halfvarson, Ailsa Hart, Fernando Magro, Charlie W Lees, Salvo Leone, Marieke J Pierik, Michele Peters, Polly Field, Helen Fishpool, Laurent Peyrin-Biro
  Journal of Crohn's and Colitis.2024; 18(1): 91.     CrossRef
• Anxiety and care experiences in adolescents with chronic health conditions: an international, longitudinal study across the transfer of care
  Anna Alanen, Mira Kallio, Evelyn Culnane, Mari Koivisto, Miko Pasanen, Sanna Salanterä, Susan Sawyer, Silja Kosola
  BMJ Paediatrics Open.2024; 8(1): e002836.     CrossRef
• Bridge study protocol: an international, observational cohort study on the transition of healthcare for adolescents with chronic conditions
  Silja Kosola, Evelyn Culnane, Hayley Loftus, Anna Tornivuori, Mira Kallio, Michelle Telfer, Päivi J Miettinen, Kaija-Leena Kolho, Kristiina Aalto, Taneli Raivio, Susan Sawyer
  BMJ Open.2021; 11(6): e048340.     CrossRef
• Efficacy of a Preparation Based on Calcium Butyrate, Bifidobacterium bifidum, Bifidobacterium lactis, and Fructooligosaccharides in the Prevention of Relapse in Ulcerative Colitis: A Prospective Observational Study
  Gian Paolo Caviglia, Federico De Blasio, Marta Vernero, Angelo Armandi, Chiara Rosso, Giorgio Maria Saracco, Elisabetta Bugianesi, Marco Astegiano, Davide Giuseppe Ribaldone
  Journal of Clinical Medicine.2021; 10(21): 4961.     CrossRef
• Similar Clinical Outcomes of Early and Late Anti-TNF Initiation for Ulcerative Colitis: A Nationwide Population-Based Study
  Minkyung Han, Yoon Suk Jung, Jae Hee Cheon, Sohee Park
  Yonsei Medical Journal.2020; 61(5): 382.     CrossRef
• Systematic Review of Development and Content Validity of Patient-reported Outcome Measures in Inflammatory Bowel Disease: Do We Measure What We Measure?
  Emma M van Andel, Brechtje D M Koopmann, Femke Crouwel, Casper G Noomen, Nanne K H de Boer, Dirk P van Asseldonk, Lidwine B Mokkink
  Journal of Crohn's and Colitis.2020; 14(9): 1299.     CrossRef
• The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study
  Marta Vernero, Federico De Blasio, Davide Giuseppe Ribaldone, Elisabetta Bugianesi, Rinaldo Pellicano, Giorgio Maria Saracco, Marco Astegiano, Gian Paolo Caviglia
  Journal of Clinical Medicine.2020; 9(12): 3941.     CrossRef
• Prediction of treatment outcome and relapse in inflammatory bowel disease
  Jun Kato, Takeichi Yoshida, Sakiko Hiraoka
  Expert Review of Clinical Immunology.2019; 15(6): 667.     CrossRef

Citations

Citations to this article as recorded by  

• Mucosal and Transmural Healing and Long-term Outcomes in Crohn’s Disease
  Bruce E Sands, Silvio Danese, J Casey Chapman, Khushboo Gurjar, Stacy Grieve, Deepika Thakur, Jenny Griffith, Namita Joshi, Kristina Kligys, Axel Dignass
  Inflammatory Bowel Diseases.2025; 31(3): 857.     CrossRef
• Is infliximab therapy currently relevant in patients with inflammatory bowel diseases? (review)
  T. L. Alexandrov, B. A. Vykova
  Koloproktologia.2024; 23(2): 173.     CrossRef
• Expression of inflammatory mediators in biofilm samples and clinical association in inflammatory bowel disease patients—a preliminary study
  Mayte Buchbender, Jakob Fehlhofer, Peter Proff, Tobias Möst, Jutta Ries, Matthias Hannig, Markus F. Neurath, Madline Gund, Raja Atreya, Marco Kesting
  Clinical Oral Investigations.2022; 26(2): 1217.     CrossRef
• Microbiota and Drug Response in Inflammatory Bowel Disease
  Martina Franzin, Katja Stefančič, Marianna Lucafò, Giuliana Decorti, Gabriele Stocco
  Pathogens.2021; 10(2): 211.     CrossRef
• Post-Induction High Adalimumab Drug Levels Predict Biological Remission at Week 24 in Patients With Crohn's Disease
  Eran Zittan, A. Hillary Steinhart, Pavel Goldstein, Raquel Milgrom, Ian M. Gralnek, Mark S. Silverberg
  Clinical and Translational Gastroenterology.2021; 12(10): e00401.     CrossRef
• Potential Utility of Therapeutic Drug Monitoring of Adalimumab in Predicting Short-Term Mucosal Healing and Histologic Remission in Pediatric Crohn's Disease Patients
  So Yoon Choi, Young Ok Choi, Yon Ho Choe, Ben Kang
  Journal of Korean Medical Science.2020;[Epub]     CrossRef
• Clinical and laboratory markers associated with anti-TNF-alpha trough levels and anti-drug antibodies in patients with inflammatory bowel diseases
  Ana B. Grinman, Maria das Graças C. de Souza, Eliete Bouskela, Ana Teresa P. Carvalho, Heitor S. P. de Souza
  Medicine.2020; 99(10): e19359.     CrossRef
• Changes in the Intestinal Microbiota of Patients with Inflammatory Bowel Disease with Clinical Remission during an 8-Week Infliximab Infusion Cycle
  Gyeol Seong, Namil Kim, Je-Gun Joung, Eun Ran Kim, Dong Kyung Chang, Jongsik Chun, Sung Noh Hong, Young-Ho Kim
  Microorganisms.2020; 8(6): 874.     CrossRef
• Patient sex does not affect endoscopic outcomes of biologicals in inflammatory bowel disease but is associated with adverse events
  Mitchell R. K. L. Lie, Emma Paulides, C. Janneke van der Woude
  International Journal of Colorectal Disease.2020; 35(8): 1489.     CrossRef
• Association of Infliximab Levels With Mucosal Healing Is Time-Dependent in Crohn’s Disease: Higher Drug Exposure Is Required Postinduction Than During Maintenance Treatment
  Ting Feng, Baili Chen, Bella Ungar, Yun Qiu, Shenghong Zhang, Jinshen He, Sinan Lin, Yao He, Zhirong Zeng, Shomron Ben-Horin, Minhu Chen, Ren Mao
  Inflammatory Bowel Diseases.2019; 25(11): 1813.     CrossRef
• Mucosal healing in inflammatory bowel disease: Expanding horizon
  Jimil Shah, Manik Lal Thakur, Usha Dutta
  Indian Journal of Gastroenterology.2019; 38(2): 98.     CrossRef

Citations

Citations to this article as recorded by  

• Advanced Endoscopic Imaging for Assessing Mucosal Healing and Histologic Remission in Inflammatory Bowel Diseases
  Tommaso Pessarelli, Gian Eugenio Tontini, Helmut Neumann
  Gastrointestinal Endoscopy Clinics of North America.2025; 35(1): 159.     CrossRef
• Fatigue in Patients with Inflammatory Bowel Disease in Remission One Year After Diagnosis (the IBSEN III Study)
  Kristina A Holten, Tomm Bernklev, Randi Opheim, Bjørn C Olsen, Trond Espen Detlie, Vibeke Strande, Petr Ricanek, Raziye Boyar, May-Bente Bengtson, Tone B Aabrekk, Øyvind Asak, Svein Oskar Frigstad, Vendel A Kristensen, Milada Hagen, Magne Henriksen, Gert
  Journal of Crohn's and Colitis.2025;[Epub]     CrossRef
• The Diagnostic Significance of SLC26A2 and Its Potential Role in Ulcerative Colitis
  Lijuan Qian, Shuo Hu, Haizhou Zhao, Ye Han, Chenguang Dai, Xinquan Zan, Qiaoming Zhi, Chunfang Xu
  Biomedicines.2025; 13(2): 461.     CrossRef
• Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysis
  Michael Youssef, Kelly Dong, So Jeong Lee, Neeraj Narula
  Inflammatory Bowel Diseases.2024; 30(1): 125.     CrossRef
• Histological Disease Activity as Predictor of Clinical Relapse, Hospitalization, and Surgery in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
  Mohammad Shehab, Sahad Al Akram, Amro Hassan, Fatema Alrashed, Vipul Jairath, Talat Bessissow
  Inflammatory Bowel Diseases.2024; 30(4): 563.     CrossRef
• Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert Consensus
  Ferdinando D’Amico, Fernando Magro, Britta Siegmund, Taku Kobayashi, Paulo Gustavo Kotze, Virginia Solitano, Benedicte Caron, Sameer Al Awadhi, Ailsa Hart, Vipul Jairath, Axel Dignass, Laurent Peyrin-Biroulet, Silvio Danese
  Inflammatory Bowel Diseases.2024; 30(6): 1009.     CrossRef
• Histological Outcomes and JAK-STAT Signalling in Ulcerative Colitis Patients Treated with Tofacitinib
  Sara van Gennep, Ivan C N Fung, Djuna C de Jong, Rishand K Ramkisoen, Esmé Clasquin, Jitteke de Jong, Leonie C S de Vries, Wouter J de Jonge, Krisztina B Gecse, Mark Löwenberg, John C Woolcott, Aart Mookhoek, Geert R D’Haens
  Journal of Crohn's and Colitis.2024; 18(8): 1283.     CrossRef
• Etrolizumab as an induction and maintenance therapy for ulcerative colitis: A systematic review and meta‐analysis of randomized controlled trials
  Othman Saleh, Mohamed T. Abuelazm, Islam Mohamed, Alaa Ramadan, Mohammad Assaf, Ahmad Alzoubi, Majd M. AlBarakat, Basel Abdelazeem
  JGH Open.2024;[Epub]     CrossRef
• Adequacy of sigmoidoscopy as compared to colonoscopy for assessment of disease activity in patients of ulcerative colitis: a prospective study
  Sameet Tariq Patel, Anuraag Jena, Sanjay Chandnani, Shubham Jain, Pankaj Nawghare, Saurabh Bansal, Harsh Gandhi, Rishikesh Malokar, Jay Chudasama, Prasanta Debnath, Seemily Kahmei, Rima Kamat, Sangeeta Kini, Qais Q Contractor, Pravin M Rathi
  Intestinal Research.2024; 22(3): 310.     CrossRef
• Deep mucosal healing in ulcerative colitis: how deep is better?
  Xin Jin, Yan You, Gechong Ruan, Weixun Zhou, Ji Li, Jingnan Li
  Frontiers in Medicine.2024;[Epub]     CrossRef
• Histologic improvement predicts endoscopic remission in patients with ulcerative colitis
  Ji Eun Kim, Minjee Kim, Min-Ji Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Sang Yun Ha, Young-Ho Kim
  Scientific Reports.2024;[Epub]     CrossRef
• Epithelial neutrophil localization and tight junction Claudin‐2 expression are innovative outcome predictors in inflammatory bowel disease
  Irene Zammarchi, Giovanni Santacroce, Miguel Puga‐Tejada, Brian Hayes, Rory Crotty, Elaine O’Driscoll, Snehali Majumder, Wiktoria Kaczmarczyk, Yasuharu Maeda, Jane McCarthy, Kathleen Sugrue, Caitriona O’Sullivan, Louise Burke, Subrata Ghosh, Marietta Iacu
  United European Gastroenterology Journal.2024; 12(9): 1155.     CrossRef
• Predictive accuracy of fecal calprotectin for histologic remission in ulcerative colitis
  Arshdeep Singh, Arshia Bhardwaj, Riya Sharma, Bhavjeet Kaur Kahlon, Ashvin Singh Dhaliwal, Dharmatma Singh, Simranjeet Kaur, Devanshi Jain, Namita Bansal, Ramit Mahajan, Kirandeep Kaur, Aminder Singh, Vikram Narang, Harpreet Kaur, Vandana Midha, Ajit Sood
  Intestinal Research.2024;[Epub]     CrossRef
• Predictive Model for Outcomes in Inflammatory Bowel Disease Patients Receiving Maintenance Infliximab Therapy
  Rochelle Wong, Paris Charilaou, Amy Hemperly, Lihui Qin, Yushan Pan, Prerna Mathani, Randy Longman, Brigid S Boland, Parambir S Dulai, Ariela K Holmer, Dana Lukin, Siddharth Singh, Mark A Valasek, William J Sandborn, Ellen Scherl, Niels Vande Casteele, Ro
  Crohn's & Colitis 360.2024;[Epub]     CrossRef
• Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1
  Gyeol Seong, Joo Hye Song, Ji Eun Kim, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Seok-Hyung Kim, Sang Yun Ha, Young-Ho Kim
  Inflammatory Bowel Diseases.2023; 29(2): 238.     CrossRef
• (Re)Appraising Remission in Ulcerative Colitis
  Ajit Sood, Arshdeep Singh, Ramit Mahajan, Vandana Midha, Charles N Bernstein, David T Rubin
  Inflammatory Bowel Diseases.2023; 29(8): 1317.     CrossRef
• Artificial Intelligence Enables Quantitative Assessment of Ulcerative Colitis Histology
  Fedaa Najdawi, Kathleen Sucipto, Pratik Mistry, Stephanie Hennek, Christina K.B. Jayson, Mary Lin, Darren Fahy, Shawn Kinsey, Ilan Wapinski, Andrew H. Beck, Murray B. Resnick, Archit Khosla, Michael G. Drage
  Modern Pathology.2023; 36(6): 100124.     CrossRef
• Impaired Intestinal Permeability Assessed by Confocal Laser Endomicroscopy—A New Potential Therapeutic Target in Inflammatory Bowel Disease
  Stefan Chiriac, Catalin Victor Sfarti, Horia Minea, Carol Stanciu, Camelia Cojocariu, Ana-Maria Singeap, Irina Girleanu, Tudor Cuciureanu, Oana Petrea, Laura Huiban, Cristina Maria Muzica, Sebastian Zenovia, Robert Nastasa, Remus Stafie, Adrian Rotaru, Er
  Diagnostics.2023; 13(7): 1230.     CrossRef
• HISTOPATHOLOGICAL FEATURES IN RELAPSE OF ULCERATIVE COLITIS.
  Saroash Iqbal, Aman Ur Rehman, Nausheen Henna, Zara Madiha, Sahar Moeed, Uzma Aslam
  JAIMC: Journal of Allama Iqbal Medical College.2023;[Epub]     CrossRef
• Mucosal Atrophy Predicts Poorer Outcomes in Pediatric Ulcerative Colitis—A National Inception Cohort Study
  Emily Stenke, Lorraine Stallard, Sarah Cooper, Anna Dominik, Abigail Pilkington, Sheila Sugrue, Maureen O’Sullivan, Michael McDermott, Shoana Quinn, Annemarie Broderick, Billy Bourke, Séamus Hussey
  Journal of Pediatric Gastroenterology & Nutrition.2023; 76(5): 603.     CrossRef
• Automating Ground Truth Annotations for Gland Segmentation Through Immunohistochemistry
  Tushar Kataria, Saradha Rajamani, Abdul Bari Ayubi, Mary Bronner, Jolanta Jedrzkiewicz, Beatrice S. Knudsen, Shireen Y. Elhabian
  Modern Pathology.2023; 36(12): 100331.     CrossRef
• Evaluation of Disease Activity in Inflammatory Bowel Disease: Diagnostic Tools in the Assessment of Histological Healing
  Alina Ecaterina Jucan, Otilia Gavrilescu, Mihaela Dranga, Iolanda Valentina Popa, Ioana-Ruxandra Mihai, Vasile-Claudiu Mihai, Gabriela Stefanescu, Vasile Liviu Drug, Cristina Cijevschi Prelipcean, Radu-Alexandru Vulpoi, Oana-Bogdana Barboi, Irina Ciortesc
  Biomedicines.2023; 11(11): 3090.     CrossRef
• Selected Cytokines and Metalloproteinases in Inflammatory Bowel Disease
  Barbara Sosna, David Aebisher, Angelika Myśliwiec, Klaudia Dynarowicz, Dorota Bartusik-Aebisher, Piotr Oleś, Grzegorz Cieślar, Aleksandra Kawczyk-Krupka
  International Journal of Molecular Sciences.2023; 25(1): 202.     CrossRef
• Utilizing Deep Learning to Analyze Whole Slide Images of Colonic Biopsies for Associations Between Eosinophil Density and Clinicopathologic Features in Active Ulcerative Colitis
  Niels Vande Casteele, Jonathan A Leighton, Shabana F Pasha, Frank Cusimano, Aart Mookhoek, Catherine E Hagen, Christophe Rosty, Reetesh K Pai, Rish K Pai
  Inflammatory Bowel Diseases.2022; 28(4): 539.     CrossRef
• Randomised clinical trial: a phase 1b study of GB004, an oral HIF‐1α stabiliser, for treatment of ulcerative colitis
  Silvio Danese, Barrett G. Levesque, Brian G. Feagan, Alina Jucov, Bal Raj Bhandari, Rish K. Pai, Kristen Taylor Meadows, Brian J. Kirby, Jean‐Marie Bruey, Allan Olson, Robin Osterhout, Courtney Van Biene, Julia Ford, Richard Aranda, Kartik Raghupathi, Wil
  Alimentary Pharmacology & Therapeutics.2022; 55(4): 401.     CrossRef
• PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system
  Xianyong Gui, Alina Bazarova, Rocìo del Amor, Michael Vieth, Gert de Hertogh, Vincenzo Villanacci, Davide Zardo, Tommaso Lorenzo Parigi, Elin Synnøve Røyset, Uday N Shivaji, Melissa Anna Teresa Monica, Giulio Mandelli, Pradeep Bhandari, Silvio Danese, Jos
  Gut.2022; 71(5): 889.     CrossRef
• Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis
  Angelo Viscido, Marco Valvano, Gianpiero Stefanelli, Annalisa Capannolo, Chiara Castellini, Eugenia Onori, Antonio Ciccone, Filippo Vernia, Giovanni Latella
  BMC Gastroenterology.2022;[Epub]     CrossRef
• Appendiceal Orifice Inflammation Is Associated with Lower Rate of Complete Endoscopic Remission in Patients with Ulcerative Colitis
  Chang Kyo Oh, Han Hee Lee, Jin Su Kim, Bo-In Lee, Young-Seok Cho
  Journal of Personalized Medicine.2022; 12(5): 748.     CrossRef
• ECCO Position on Harmonisation of Crohn’s Disease Mucosal Histopathology
  F Magro, J Sabino, F Rosini, M Tripathi, P Borralho, P Baldin, S Danese, A Driessen, I O Gordon, M Iacucci, N Noor, M Svrcek, L Peyrin-Biroulet, R Feakins
  Journal of Crohn's and Colitis.2022; 16(6): 876.     CrossRef
• Constrained multiple instance learning for ulcerative colitis prediction using histological images
  Rocío del Amor, Pablo Meseguer, Tommaso Lorenzo Parigi, Vincenzo Villanacci, Adrián Colomer, Laëtitia Launet, Alina Bazarova, Gian Eugenio Tontini, Raf Bisschops, Gert de Hertogh, Jose G. Ferraz, Martin Götz, Xianyong Gui, Bu’Hussain Hayee, Mark Lazarev,
  Computer Methods and Programs in Biomedicine.2022; 224: 107012.     CrossRef
• Ulcerative colitis: Impact of early disease clearance on long‐term outcomes ‐ A multicenter cohort study
  Ferdinando D’Amico, Gionata Fiorino, Virginia Solitano, Eugenia Massarini, Lucas Guillo, Mariangela Allocca, Federica Furfaro, Alessandra Zilli, Stefanos Bonovas, Fernando Magro, Laurent Peyrin‐Biroulet, Silvio Danese
  United European Gastroenterology Journal.2022; 10(7): 775.     CrossRef
• Efficacy and safety of ozanimod for ulcerative colitis (review)
  M. V. Shapina, A. V. Poletova, T. A. Baranova
  Koloproktologia.2022; 21(3): 119.     CrossRef
• Deep learning-based automated quantification of goblet cell mucus using histological images as a predictor of clinical relapse of ulcerative colitis with endoscopic remission
  Jun Ohara, Tetsuo Nemoto, Yasuharu Maeda, Noriyuki Ogata, Shin-ei Kudo, Toshiko Yamochi
  Journal of Gastroenterology.2022; 57(12): 962.     CrossRef
• Clinical Predictors of Response to Faecal Microbiota Transplantation in Patients with Active Ulcerative Colitis
  Ajit Sood, Arshdeep Singh, Ramit Mahajan, Vandana Midha, Kirandeep Kaur, Dharmatma Singh, Namita Bansal, Khushdeep Dharni
  Journal of Crohn's and Colitis.2021; 15(2): 238.     CrossRef
• Therapeutic drug monitoring of anti‐tumour necrosis factor‐α agents in inflammatory bowel disease: Limits and improvements
  José María Giráldez‐Montero, Jaime Gonzalez‐Lopez, Manuel Campos‐Toimil, María Jesús Lamas‐Díaz
  British Journal of Clinical Pharmacology.2021; 87(5): 2216.     CrossRef
• Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After Biopsy
  Fernando Magro, Catarina Alves, Joanne Lopes, Susana Lopes, Helena Tavares de Sousa, José Cotter, Vitor Macedo da Silva, Paula Lago, Ana Vieira, Mariana Brito, Maria A.M. Duarte, Francisco Portela, João P. Silva, Paula Ministro, Bruno Arroja, Liliana Carv
  Clinical Gastroenterology and Hepatology.2021; 19(12): 2567.     CrossRef
• Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis
  Akshita Gupta, Amy Yu, Laurent Peyrin-Biroulet, Ashwin N. Ananthakrishnan
  Clinical Gastroenterology and Hepatology.2021; 19(9): 1800.     CrossRef
• Fecal calprotectin as a noninvasive test to predict deep remission in patients with ulcerative colitis
  Ludimilla dos Reis Malvão, Kalil Madi, Barbara Cathalá Esberard, Renata Fernandes de Amorim, Kelly dos Santos Silva, Katia Farias e Silva, Heitor Siffert Pereira de Souza, Ana Teresa Pugas Carvalho
  Medicine.2021; 100(3): e24058.     CrossRef
• Real-life evaluation of histologic scores for Ulcerative Colitis in remission
  Christian Børde Arkteg, Sveinung Wergeland Sørbye, Lene Buhl Riis, Stig Manfred Dalen, Jon Florholmen, Rasmus Goll, Valérie Pittet
  PLOS ONE.2021; 16(3): e0248224.     CrossRef
• Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study
  William J Sandborn, Brian G Feagan, Stephen Hanauer, Severine Vermeire, Subrata Ghosh, Wenzhong J Liu, AnnKatrin Petersen, Lorna Charles, Vivian Huang, Keith Usiskin, Douglas C Wolf, Geert D’Haens
  Journal of Crohn's and Colitis.2021; 15(7): 1120.     CrossRef
• Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission
  Marietta Iacucci, Louisa Jeffery, Animesh Acharjee, Olga Maria Nardone, Davide Zardo, Samuel C L Smith, Alina Bazarova, Rosanna Cannatelli, Uday N Shivaji, John Williams, Georgios Gkoutos, Subrata Ghosh
  Inflammatory Bowel Diseases.2021; 27(11): 1719.     CrossRef
• Raman spectroscopy accurately differentiates mucosal healing from non-healing and biochemical changes following biological therapy in inflammatory bowel disease
  Samuel C. L. Smith, Carl Banbury, Davide Zardo, Rosanna Cannatelli, Olga M. Nardone, Uday N. Shivaji, Subrata Ghosh, Pola Goldberg Oppenheimer, Marietta Iacucci, Pradeep Dudeja
  PLOS ONE.2021; 16(6): e0252210.     CrossRef
• Accurate diagnosis of endoscopic mucosal healing in ulcerative colitis using deep learning and machine learning
  Tien-Yu Huang, Shan-Quan Zhan, Peng-Jen Chen, Chih-Wei Yang, Henry Horng-Shing Lu
  Journal of the Chinese Medical Association.2021; 84(7): 678.     CrossRef
• Is histological remission of ulcerative colitis achievable?
  Oleg V. Knyazev, Anna V. Kagramanova, Sergei G. Khomeriki, Asfold I. Parfenov
  Terapevticheskii arkhiv.2021; 93(8): 975.     CrossRef
• Current Trends in IBD—Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System
  Yunki Y Yau, Valerie C Wasinger, Robert P Hirten, Emil Chuang, Merodean Huntsman, Jack Stylli, Jeff Shimizu, Vijay Yajnik, Jeffrey Smith, Shaoying N Lee, Sharat Singh, Christopher Wahl, Rupert W Leong, Bruce E Sands
  Inflammatory Bowel Diseases.2021; 27(Supplement): S17.     CrossRef
• Histological remission of ulcerative colitis with combined anti-cytokine and cell therapy
  Oleg V. Knyazev, Sergey G. Khomeriki, Аnna V. Kagramanova, Albina A. Lishchinskaya, Olga A. Smirnova, Karina K. Noskova, Asfold I. Parfenov
  Terapevticheskii arkhiv.2021; 93(12): 1435.     CrossRef
• Histologic Activity and Steroid Use History are Risk Factors of Clinical Relapse in Ulcerative Colitis with Endoscopic Remission
  Gyeol Seong, Joo Hye Song, Ji Eun Kim, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Seok-Hyung Kim, Sang Yun Ha, Young-Ho Kim
  SSRN Electronic Journal .2021;[Epub]     CrossRef
• Relationship between Mayo endoscopic score and histological scores in ulcerative colitis: A prospective study
  Jimil Shah, Usha Dutta, Ashim Das, Vishal Sharma, Harshal Mandavdhare, Pankaj Sharma, Dimple Kalsi, Priyanka Popli, Rakesh Kochhar
  JGH Open.2020; 4(3): 382.     CrossRef
• Complete Resolution of Mucosal Neutrophils Associates With Improved Long-Term Clinical Outcomes of Patients With Ulcerative Colitis
  Rish K. Pai, Douglas J. Hartman, Claudia Ramos Rivers, Miguel Regueiro, Marc Schwartz, David G. Binion, Reetesh K. Pai
  Clinical Gastroenterology and Hepatology.2020; 18(11): 2510.     CrossRef
• Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis
  Natsuki Ishida, Takahiro Miyazu, Ryosuke Takano, Satoshi Tamura, Shinya Tani, Takuma Kagami, Mihoko Yamade, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Takahisa Furuta, Hiroaki Miyajima, Ken Sugimoto
  BMC Gastroenterology.2020;[Epub]     CrossRef
• ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology
  Fernando Magro, Glen Doherty, Laurent Peyrin-Biroulet, Magali Svrcek, Paula Borralho, Alissa Walsh, Fatima Carneiro, Francesca Rosini, Gert de Hertogh, Luc Biedermann, Lieven Pouillon, Michael Scharl, Monika Tripathi, Silvio Danese, Vincenzo Villanacci, R
  Journal of Crohn's and Colitis.2020; 14(11): 1503.     CrossRef
• Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment
  Lorenzo Bertani, Maria Gloria Mumolo, Gherardo Tapete, Eleonora Albano, Giovanni Baiano Svizzero, Federico Zanzi, Linda Ceccarelli, Massimo Bellini, Santino Marchi, Francesco Costa
  European Journal of Gastroenterology & Hepatology.2020; 32(9): 1091.     CrossRef
• What is the appropriate cut-off value of CRP to predict endoscopic remission in patients with ulcerative colitis in clinical remission?
  Jongbeom Shin, Sung Min Kong, Gyeol Seong, Young-Ho Kim
  International Journal of Colorectal Disease.2020; 35(12): 2249.     CrossRef
• Treat to target or ‘treat to clear’ in inflammatory bowel diseases: one step further?
  Arianna Dal Buono, Giulia Roda, Marjorie Argollo, Eirini Zacharopoulou, Laurent Peyrin-Biroulet, Silvio Danese
  Expert Review of Gastroenterology & Hepatology.2020; 14(9): 807.     CrossRef
• Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis
  Hyuk Yoon, Sushrut Jangi, Parambir S. Dulai, Brigid S. Boland, Larry J. Prokop, Vipul Jairath, Brian G. Feagan, William J. Sandborn, Siddharth Singh
  Gastroenterology.2020; 159(4): 1262.     CrossRef
• Assessing Severity of Disease in Patients with Ulcerative Colitis
  Baldeep Singh Pabla, David Allen Schwartz
  Gastroenterology Clinics of North America.2020; 49(4): 671.     CrossRef
• Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
  Ajit Sood, Vineet Ahuja, Vandana Midha, Saroj Kant Sinha, C. Ganesh Pai, Saurabh Kedia, Varun Mehta, Sawan Bopanna, Philip Abraham, Rupa Banerjee, Shobna Bhatia, Karmabir Chakravartty, Sunil Dadhich, Devendra Desai, Manisha Dwivedi, Bhabhadev Goswami, Kir
  Intestinal Research.2020; 18(4): 355.     CrossRef
• ‘Treat to Target’ in Mild to Moderate Ulcerative Colitis: Evidence to Support this Strategy
  Arianna Dal Buono, Giulia Roda, Marjorie Argollo, Kristine Paridaens, Laurent Peyrin-Biroulet, Silvio Danese
  Current Drug Targets.2020; 22(1): 117.     CrossRef
• What is the role of histopathology in the evaluation of disease activity in Crohn’s Disease?
  Rish K. Pai, Vipul Jairath
  Best Practice & Research Clinical Gastroenterology.2019;[Epub]     CrossRef
• Vedolizumab Trough Levels and Histological Healing During Maintenance Therapy in Ulcerative Colitis
  Lieven Pouillon, Hélène Rousseau, Hélène Busby-Venner, Marcelo De Carvalho Bittencourt, Myriam Choukour, Guillaume Gauchotte, Camille Zallot, Silvio Danese, Cédric Baumann, Laurent Peyrin-Biroulet
  Journal of Crohn's and Colitis.2019; 13(8): 970.     CrossRef
• Prediction of treatment outcome and relapse in inflammatory bowel disease
  Jun Kato, Takeichi Yoshida, Sakiko Hiraoka
  Expert Review of Clinical Immunology.2019; 15(6): 667.     CrossRef
• Role of Faecal Microbiota Transplantation for Maintenance of Remission in Patients With Ulcerative Colitis: A Pilot Study
  Ajit Sood, Ramit Mahajan, Arshdeep Singh, Vandana Midha, Varun Mehta, Vikram Narang, Tarundeep Singh, Anmol Singh Pannu
  Journal of Crohn's and Colitis.2019; 13(10): 1311.     CrossRef
• Mucosal healing in inflammatory bowel disease: Expanding horizon
  Jimil Shah, Manik Lal Thakur, Usha Dutta
  Indian Journal of Gastroenterology.2019; 38(2): 98.     CrossRef
• A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review
  Ryan Ungaro, Jean-Frédéric Colombel, Trevor Lissoos, Laurent Peyrin-Biroulet
  American Journal of Gastroenterology.2019; 114(6): 874.     CrossRef
• A Simplified Definition of Histologic Improvement in Ulcerative Colitis and its Association With Disease Outcomes up to 30 Weeks from Initiation of Therapy: Post Hoc Analysis of Three Clinical Trials
  Katherine Li, Richard Strauss, Colleen Marano, Linda E Greenbaum, Joshua R Friedman, Laurent Peyrin-Biroulet, Carrie Brodmerkel, Gert De Hertogh
  Journal of Crohn's and Colitis.2019; 13(8): 1025.     CrossRef
• Can advanced endoscopic techniques for assessment of mucosal inflammation and healing approximate histology in inflammatory bowel disease?
  Olga Maria Nardone, Rosanna Cannatelli, Davide Zardo, Subrata Ghosh, Iacucci Marietta
  Therapeutic Advances in Gastroenterology.2019;[Epub]     CrossRef
• The emerging role of histologic disease activity assessment in ulcerative colitis
  Rish K. Pai, Vipul Jairath, Niels Vande Casteele, Florian Rieder, Claire E. Parker, Gregory Y. Lauwers
  Gastrointestinal Endoscopy.2018; 88(6): 887.     CrossRef
• Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis
  Natalia Schneider Nunes, Saejeong Kim, Maggie Sundby, Parwathy Chandran, Scott Robert Burks, Ana Helena Paz, Joseph Alan Frank
  World Journal of Gastroenterology.2018; 24(38): 4341.     CrossRef
• Can histologic remission be a better prognostic factor and therapeutic target beyond endoscopic mucosal healing in patients with ulcerative colitis?
  Hyo Jun Ahn, Sang-Bum Kang
  Intestinal Research.2018; 16(1): 1.     CrossRef

Behçet's disease (BD) is a chronic relapsing disease involving multiple organ systems. BD is characterized clinically by oral and genital aphthae, cutaneous lesions, and ophthalmological, neurological, and/or gastrointestinal manifestations. It is widely recognized that the presence of intestinal lesions may be a poor prognostic factor in intestinal BD, increasing the risk of surgery and decreasing the quality of life. Despite this, the management of intestinal BD has not been standardized. Empirical therapies including 5-aminosalicylic acid and corticosteroids have been used anecdotally to treat intestinal BD, but recent studies have provided evidence for the efficacy of anti-tumor necrosis factor α monoclonal antibodies. The development of agents targeting tumor necrosis factor α continues, it seems likely that they will change the therapeutic strategy and clinical outcomes of intestinal BD and inflammatory bowel disease. Monitoring disease activity such as endoscopic evaluation will become more important to obtain better outcomes. Here, we review current and future perspectives in the treatment and outcomes of intestinal BD.

Citations

Citations to this article as recorded by  

• Behçet’s disease: incidence, prevalence, and real-word data on the use of biologic agents in Japan
  Tadakazu Hisamatsu, Makoto Naganuma, Philippe Pinton, Mitsuhiro Takeno
  Journal of Gastroenterology.2025; 60(3): 294.     CrossRef
• Impact of age at diagnosis on long‐term prognosis in patients with intestinal Behçet's disease
  Ji Young Chang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon, Jihye Park
  Journal of Gastroenterology and Hepatology.2024; 39(3): 519.     CrossRef
• Behçet's syndrome
  Giacomo Emmi, Alessandra Bettiol, Gülen Hatemi, Domenico Prisco
  The Lancet.2024; 403(10431): 1093.     CrossRef
• Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease
  Hye Kyung Hyun, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon
  European Journal of Gastroenterology & Hepatology.2024; 36(4): 445.     CrossRef
• Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study
  Jung-Bin Park, So Jung Han, Seung Bum Lee, Dong Hyun Kim, Jae Hee Cheon, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Soo Jung Park, Sang Hyoung Park
  Yonsei Medical Journal.2024; 65(5): 265.     CrossRef
• Behçet disease: epidemiology, classification criteria and treatment modalities
  Alia Fazaa, Yasmine Makhlouf, Faiza Ben Massoud, Saoussen Miladi, Hiba Boussaa, Kmar Ouenniche, Leila Souebni, Selma Kassab, Selma Chekili, Kawther Ben Abdelghani, Ahmed Laatar
  Expert Review of Clinical Immunology.2024; 20(12): 1437.     CrossRef
• Risk Factors for Surgery in Patients with Intestinal Behçet’s Disease During Anti-Tumor Necrosis Factor-Alpha Therapy
  So Jung Han, Eun Ae Kang, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Won Ho Kim, Jae Hee Cheon
  Yonsei Medical Journal.2023; 64(2): 111.     CrossRef
• Possible Association of Mutations in the MEFV Gene with the Intestinal Phenotype of Behçet’s Disease and Refractoriness to Treatment
  Yoki Furuta, Ryosuke Gushima, Hideaki Naoe, Munenori Honda, Yuiko Tsuruta, Katsuya Nagaoka, Takehisa Watanabe, Masakuni Tateyama, Nahoko Fujimoto, Shinya Hirata, Eiko Miyagawa, Komei Sakata, Yumiko Mizuhashi, Mikako Iwakura, Masayuki Murai, Masao Matsuoka
  Journal of Clinical Medicine.2023; 12(9): 3131.     CrossRef
• Immune‐mediated inflammatory diseases of the gastrointestinal tract: Beyond Crohn's disease and ulcerative colitis
  Sudheer K Vuyyuru, Saurabh Kedia, Pabitra Sahu, Vineet Ahuja
  JGH Open.2022; 6(2): 100.     CrossRef
• Mucosal healing in intestinal Behçet's disease: A systematic review and meta‐analysis
  Liang Gong, Yue Lun Zhang, Lu Xi Sun, Guo Rong Chen, Dong Wu
  Journal of Digestive Diseases.2021; 22(2): 83.     CrossRef
• Experimental Therapeutic Solutions for Behcet’s Disease
  Burçin Cansu Bozca, Erkan Alpsoy
  Journal of Experimental Pharmacology.2021; Volume 13: 127.     CrossRef
• Treatment of Behçet's Disease: An Algorithmic Multidisciplinary Approach
  Erkan Alpsoy, Pietro Leccese, Giacomo Emmi, Shigeaki Ohno
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Behçet Disease: An Update for Dermatologists
  Erkan Alpsoy, Burcin Cansu Bozca, Asli Bilgic
  American Journal of Clinical Dermatology.2021; 22(4): 477.     CrossRef
• Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study
  Yasuo Suzuki, Takashi Hagiwara, Mariko Kobayashi, Kazuo Morita, Tomoyo Shimamoto, Toshifumi Hibi
  Intestinal Research.2021; 19(3): 301.     CrossRef
• Is fasting beneficial for hospitalized patients with inflammatory bowel diseases?
  Yong Eun Park, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim, Jung Nam Kim, Na Rae Lee, Jae Hee Cheon
  Intestinal Research.2020; 18(1): 85.     CrossRef
• Elevated fecal calprotectin and lactoferrin associated with small intestinal lesions in patients with Behçet disease
  Mari Hayashida, Jun Miyoshi, Tatsuya Mitsui, Miki Miura, Daisuke Saito, Akihito Sakuraba, Soko Kawashima, Noriko Ikegaya, Kazuhito Fukuoka, Miho Karube, Yoshinori Komagata, Shinya Kaname, Annabelle A Okada, Shunji Fujimori, Minoru Matsuura, Tadakazu Hisam
  Journal of Gastroenterology and Hepatology.2020; 35(8): 1340.     CrossRef
• Successful combination therapy using adalimumab and 5-aminosalicylic acid for a resistant case of intestinal Behçet’s disease
  H. J. Kim, K.‑t. Kim, S.-G. Lee, Y. Kim
  Zeitschrift für Rheumatologie.2020; 79(7): 702.     CrossRef
• Update on the treatment of Behçet’s syndrome
  Sinem Nihal Esatoglu, Gulen Hatemi
  Internal and Emergency Medicine.2019; 14(5): 661.     CrossRef
• Behсet's disease: intestinal damage
  R. G. Goloeva, Z. S. Alekberova
  Rheumatology Science and Practice.2019; 56(6): 767.     CrossRef
• Intestinal manifestations of Behçet's disease
  R G Goloeva, Z S Alekberova, T A Lisitsyna, E A Stepanova, L P Orlova
  Terapevticheskii arkhiv.2019; 91(5): 111.     CrossRef
• The outcomes and risk factors of early readmission in patients with intestinal Behçet’s disease
  Yong Eun Park, Jae Hee Cheon, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim
  Clinical Rheumatology.2018; 37(7): 1913.     CrossRef
• Cancer Risk in Patients with Intestinal Behçet’s Disease: A Nationwide Population-Based Study
  Minkyung Han, Yoon Suk Jung, Won Ho Kim, Jae Hee Cheon, Sohee Park
  Gut and Liver.2018; 12(4): 433.     CrossRef
• Updated treatment strategies for intestinal Behçet’s disease
  Yong Eun Park, Jae Hee Cheon
  The Korean Journal of Internal Medicine.2018; 33(1): 1.     CrossRef
• Small Bowel Lesions Mimicking Crohn’s Disease
  David B. Sachar
  Current Gastroenterology Reports.2018;[Epub]     CrossRef
• Anti-Tumor Necrosis Factor Therapy in Intestinal Beh Ccedil;et rsquo;s Disease
  Jihye Park, Jae Hee Cheon
  Gut and Liver.2018; 12(6): 623.     CrossRef

Citations

Citations to this article as recorded by  

• Deep mucosal healing in ulcerative colitis: how deep is better?
  Xin Jin, Yan You, Gechong Ruan, Weixun Zhou, Ji Li, Jingnan Li
  Frontiers in Medicine.2024;[Epub]     CrossRef
• Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis
  Angelo Viscido, Marco Valvano, Gianpiero Stefanelli, Annalisa Capannolo, Chiara Castellini, Eugenia Onori, Antonio Ciccone, Filippo Vernia, Giovanni Latella
  BMC Gastroenterology.2022;[Epub]     CrossRef
• Predicting Ulcerative Colitis Relapse in Clinical Remission With Fecal Immunochemical Occult Blood Test or Prostaglandin E-Major Urinary Metabolite
  Natsuki Ishida, Tomoharu Matsuura, Yusuke Asai, Takahiro Miyazu, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
  Clinical and Translational Gastroenterology.2022; 13(7): e00501.     CrossRef
• Further research on the clinical relevance of the ulcerative colitis colonoscopic index of severity for predicting 5-year relapse
  Natsuki Ishida, Shunya Onoue, Takahiro Miyazu, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
  International Journal of Colorectal Disease.2021; 36(12): 2661.     CrossRef
• Predictive factors for achievement of mucosal healing by budesonide 2-mg foam in ulcerative colitis: a pooled analysis of data from two clinical trials
  Toshifumi Hibi, Makoto Naganuma, Eisei Oda, Yoji Yamada, Yoshitomo Chujoh, Ryoichi Yoshihara, Mamoru Watanabe
  Intestinal Research.2020; 18(1): 56.     CrossRef
• Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis
  Hyuk Yoon, Sushrut Jangi, Parambir S. Dulai, Brigid S. Boland, Larry J. Prokop, Vipul Jairath, Brian G. Feagan, William J. Sandborn, Siddharth Singh
  Gastroenterology.2020; 159(4): 1262.     CrossRef
• Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam
  Makoto Naganuma, Fumihito Hirai, Kiyonori Kobayashi, Kenji Watanabe, Ken Takeuchi, Nobuo Aoyama, Hiroshi Nozawa, Satoshi Motoya, Toshihide Ohmori, Akio Harada, Yushi Nagai, Takayuki Abe, Yoji Yamada, Katsutoshi Inagaki, Naoki Shimizu, Takanori Kanai, Mamo
  PLOS ONE.2019; 14(8): e0220413.     CrossRef
• Endoscopic score vs. fecal biomarkers for predicting relapse in patients with ulcerative colitis after clinical remission and mucosal healing
  Takayuki Yamamoto, Takahiro Shimoyama, Satoru Umegae, Koichi Matsumoto
  Clinical and Translational Gastroenterology.2018; 9(3): e136.     CrossRef
• European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel Disease
  Glen Doherty, Konstantinos H Katsanos, Johan Burisch, Matthieu Allez, Konstantinos Papamichael, Andreas Stallmach, Ren Mao, Ingrid Prytz Berset, Javier P Gisbert, Shaji Sebastian, Jarosław Kierkuś, Loris Lopetuso, Edyta Szymanska, Edouard Louis
  Journal of Crohn's and Colitis.2018; 12(1): 17.     CrossRef
• Evaluation of the Potential Antioxidant Role of High-Density Lipoprotein-Cholesterol (HDL-C) in Patients with Ulcerative Colitis
  Mostafa Vaghari Tabari, Soheila Moein, Durdi Qujeq, Mehrdad Kashifard, Javaad Shokri Shirvani, Karimollah Hajian Tilaki, Gholamreza Farshidfar
  Annals of Colorectal Research.2017;[Epub]     CrossRef